3. Umbruch 4.4..2005 - Online Pot

More documents

Recommendations

Info

Milestones in Drug Therapy MDT Series Editors Prof. Michael J. Parnham, PhD Prof. Dr. J. Bruinvels Senior Scientific Advisor Sweelincklaan 75 PLIVA Research Institute Ltd NL-3723 JC Bilthoven Prilaz baruna Filipovića 29 The Netherlands HR-10000 Zagreb Croatia
Page 2: (( 3. Umbruch 4.4..2005 ))
Page 8: Editor Raphael Mechoulam Medical Fa
Page 12: VI Daniela Parolaro and Tiziana Rub
Page 16: VIII List of contributors Piazza A.
Page 20: X Preface ing endocannabinoids with
Page 24: 2 E. Russo Good health in Ayurveda
Page 28: 4 E. Russo Table 1. Indian names fo
Page 32: 6 E. Russo The 18th century Persian
Page 36: 8 E. Russo fering from chronic rheu
Page 40: 10 E. Russo Similarly, by 1954, can
Page 44: 12 E. Russo (energy modality or pot
Page 48: 14 E. Russo Table 2. (Continued) Ca
Page 52: 16 E. Russo Hemorrhoids continue to
Page 56:
18 E. Russo 2 Merlin MD (2003) Arch
Page 60:
20 E. Russo 63 Karnick CR (1996) Ay
Page 64:
22 E. Russo medical use of cannabis
Page 68:
24 L.O. Hanusˇ and R. Mechoulam In
Page 72:
26 L.O. Hanusˇ and R. Mechoulam wh
Page 76:
28 L.O. Hanusˇ and R. Mechoulam we
Page 80:
30 L.O. Hanusˇ and R. Mechoulam St
Page 84:
32 L.O. Hanusˇ and R. Mechoulam (R
Page 88:
Page 92:
36 L.O. Hanusˇ and R. Mechoulam No
Page 96:
Page 100:
Page 104:
42 L.O. Hanusˇ and R. Mechoulam of
Page 108:
44 L.O. Hanusˇ and R. Mechoulam Ku
Page 112:
46 M. Maccarrone 117 Huffman JW, Ze
Page 116:
48 R.G. Pertwee ed that, in contras
Page 120:
50 R.G. Pertwee rats and mice at do
Page 124:
52 R.G. Pertwee prevent petit mal e
Page 128:
54 R.G. Pertwee Neurotoxicity As di
Page 132:
56 R.G. Pertwee Table 3. Anti-infla
Page 136:
58 R.G. Pertwee followed by sleep,
Page 140:
60 R.G. Pertwee or cancer against w
Page 144:
62 R.G. Pertwee cannabidiol with ph
Page 148:
64 R.G. Pertwee choactivity. In: DJ
Page 152:
Cannabinoids as Therapeutics Edited
Page 156:
Endocannabinoids and regulation of
Page 160:
Page 164:
Page 168:
Page 172:
Page 176:
Page 180:
Cannabinoids in neurodegeneration a
Page 184:
Page 188:
Page 192:
Page 196:
Page 200:
Page 204:
Page 208:
Page 212:
Page 216:
Page 220:
Page 224:
Page 228:
Page 232:
Page 236:
Page 240:
112 S.A. Varvel and A.H. Lichtman a
Page 244:
114 S.A. Varvel and A.H. Lichtman T
Page 248:
116 S.A. Varvel and A.H. Lichtman c
Page 252:
118 S.A. Varvel and A.H. Lichtman A
Page 256:
120 S.A. Varvel and A.H. Lichtman T
Page 260:
122 S.A. Varvel and A.H. Lichtman p
Page 264:
124 S.A. Varvel and A.H. Lichtman n
Page 268:
126 S.A. Varvel and A.H. Lichtman e
Page 272:
128 S.A. Varvel and A.H. Lichtman m
Page 276:
130 S.A. Varvel and A.H. Lichtman b
Page 280:
132 S.A. Varvel and A.H. Lichtman C
Page 284:
134 S.A. Varvel and A.H. Lichtman a
Page 288:
136 S.A. Varvel and A.H. Lichtman 8
Page 292:
138 S.A. Varvel and A.H. Lichtman u
Page 296:
140 S.A. Varvel and A.H. Lichtman d
Page 300:
142 R.E. Musty Since the discovery
Page 304:
144 R.E. Musty effects. Low doses s
Page 308:
146 R.E. Musty Discussion The data
Page 312:
Page 316:
Cannabinoid targets for pain therap
Page 320:
Page 324:
Page 328:
Page 332:
Page 336:
Page 340:
Page 344:
Page 348:
Potential use of cannabimimetics in
Page 352:
Page 356:
Page 360:
Page 364:
Page 368:
Page 372:
Page 376:
Page 380:
184 L.A. Parker et al. 5-HT 3 antag
Page 384:
186 L.A. Parker et al. ing nausea,
Page 388:
188 L.A. Parker et al. Cats and dog
Page 392:
190 L.A. Parker et al. [27] indicat
Page 396:
192 L.A. Parker et al. Anecdotal ev
Page 400:
194 L.A. Parker et al. specific to
Page 404:
196 L.A. Parker et al. References 1
Page 408:
198 L.A. Parker et al. 45 Mechoulam
Page 412:
200 L.A. Parker et al. norvegicus d
Page 416:
202 I.A. Bab signaling [20, 21] as
Page 420:
204 I.A. Bab cular and cellular bio
Page 424:
206 I.A. Bab 39 Iuliano-Burns S, Mi
Page 428:
208 D. Parolaro and T. Rubino (Amer
Page 432:
210 D. Parolaro and T. Rubino addic
Page 436:
212 D. Parolaro and T. Rubino Condi
Page 440:
214 D. Parolaro and T. Rubino plete
Page 444:
216 D. Parolaro and T. Rubino prote
Page 448:
218 D. Parolaro and T. Rubino Exp T
Page 452:
220 F. Barth and M. Rinaldi-Carmona
Page 456:
Page 460:
Page 464:
Page 468:
Page 472:
Page 476:
232 G.W. Guy and C.G. Stott However
Page 480:
234 G.W. Guy and C.G. Stott In the
Page 484:
236 G.W. Guy and C.G. Stott ∆ 9 -
Page 488:
238 G.W. Guy and C.G. Stott Figure
Page 492:
240 G.W. Guy and C.G. Stott For the
Page 496:
Page 500:
244 G.W. Guy and C.G. Stott oxide,
Page 504:
246 G.W. Guy and C.G. Stott Ireland
Page 508:
Page 512:
Page 516:
252 G.W. Guy and C.G. Stott Table 2
Page 520:
254 G.W. Guy and C.G. Stott of the
Page 524:
256 G.W. Guy and C.G. Stott reactio
Page 528:
Page 532:
260 G.W. Guy and C.G. Stott easily
Page 536:
262 G.W. Guy and C.G. Stott 40 Walt
Page 540:
Index AA-5-HT 156 absent-mindedness
Page 544:
Index 267 cannabinoid agonist 190,
Page 548:
Index 269 HU-210 93, 95, 142, 153,
Page 552:
Index 271 oxidative cell death 84 o
show all

3. Umbruch 4.4..2005 - Online Pot

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?